• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.
    Medicaid program seeks federal waiver to expand drug treatment options
    Waiving IMD Exclusion also would help those with mental health disorders
    Baltimore, MD (July 28, 2015) – The Department of Health and Mental Hygiene (DHMH) is seeking a federal waiver from the Institution for Mental Diseases (IMD) Exclusion (also known as the “IMD Exclusion”). This waiver would significantly expand the scope of treatment options available to Medicaid enrollees with substance use and mental health disorders.
    “This waiver would allow adult Medicaid enrollees to receive services in private IMD facilities that are dedicated to treating their specific needs and would promote access to high-quality, specialized care.” said Shannon McMahon, DHMH’s Deputy Secretary for Health Care Financing, which houses Maryland’s Medicaid program. “The waiver also would allow the state to leverage federal funds for these services.”
    The federal IMD Exclusion prohibits Medicaid reimbursement for adults between the ages of 21 and 64 who are receiving services provided in “a hospital, nursing facility, or other institution of more than 16 beds that is primarily engaged in providing diagnosis, treatment, or care of persons with mental diseases, including medical attention, nursing care and treatment of individuals with mental diseases.” Because of this non-payment policy, many Medicaid enrollees with acute psychiatric and addiction treatment needs are referred to hospital emergency departments and general acute care inpatient units, rather than smaller, community-based specialized providers with expertise to care for these individuals. 
    If the U.S. Centers for Medicare and Medicaid Services approve Maryland’s waiver application, Maryland will be able to reimburse IMDs for the treatment of Medicaid enrollees aged 21-64 with acute psychiatric and substance-use-related needs and would receive federal matching dollars. Cost savings would be generated at both the state and federal levels by enabling the state to pay for appropriate care in appropriate settings.
    Maryland pursuing this waiver amendment has drawn significant support from key stakeholders, including the Maryland Hospital Association, the Maryland Chapter of the National Council of Alcoholism and Drug Dependence, and numerous community providers. Moreover, it presents an opportunity to align clinical and financial goals making it advantageous for both payers and beneficiaries.
    Documents related to the waiver application are posted on DHMH’s website at http://dhmh.maryland.gov/pages/IMD-Exclusion-Waiver.aspx​​
    The Maryland Department of Health and Mental Hygiene is the state government agency that protects Maryland’s public health and also works to help Marylanders make better health decisions for better health outcomes. Stay connected: www.twitter.com/MarylandDHMH and www.facebook.com/MarylandDHMH.